Tarsus Pharmaceuticals, Inc. TARS Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Tarsus Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s current ratio?
- Tarsus Pharmaceuticals, Inc. (TARS) reported current ratio of 3.7× in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s current ratio changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s current ratio decreased by 32.8% year-over-year, from 5.6× to 3.7×.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s current ratio has grown at a -34.4% compound annual growth rate (CAGR), from 31.7× to 3.9×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.